Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Matthew Wein

See Remarks at Metagenomi Therapeutics, Inc. (MGX); See Remarks at Metagenomi, Inc. (MGX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 10SEC MGXMetagenomi Therapeutics, Inc. Sell 358126,133 held (−0%) $1.16 $415 -13.8%
Jun 10SEC MGXMetagenomi Therapeutics, Inc. Sell 558126,491 held (−0%) $1.30 $725 -23.1%
Mar 9SEC MGXMetagenomi Therapeutics, Inc. Sell 482114,549 held (−0%) $1.60 $771 -37.5%
Dec 8SEC MGXMetagenomi, Inc. Sell 199115,031 held (−0%) $1.77 $352 -43.5%
Dec 1SEC MGXMetagenomi, Inc. Sell 19919,230 held (−1%) $1.81 $360 -44.8%